In addition, our study reveals the roles of hnRNPA2B1 and RBFOX2 in SON-mediated alternative splicing, suggesting that RBFOX2 and hnRNPA2B1 status should be carefully considered when targeting SON in GBM. This evidence concerns the gene HNRNPA2B1 and glioblastoma.